Legal status · United States
Is Beinaglutide legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Beinaglutide is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Beinaglutide in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | No FDA approval. Approved and marketed in China, including a weight management indication granted in July 2023. |
| FDA approval status | Not approved in the United States. Marketed in China for type 2 diabetes, and approved by China's National Medical Products Administration in July 2023 for weight management. |
| Human studies cited | 3 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Beinaglutide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Beinaglutide is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Beinaglutide is
The only marketed GLP-1 drug that is the unmodified human hormone, which is why it has to be injected three times a day. Approved in China, and in a 427 person phase 3 it produced 6.0 percent weight loss against 2.4 percent on placebo over 16 weeks.
Every other drug in this class is the human hormone rebuilt to survive in the bloodstream: an amino acid swapped to resist the enzyme that degrades it, a fatty acid chain added to bind albumin, a protein domain fused on to slow clearance. Beinaglutide is none of that.
Mechanism: Recombinant human glucagon-like peptide-1 (7-36) amide, produced in a recombinant system and identical in sequence to the endogenous hormone. It activates the GLP-1 receptor exactly as the native hormone does: glucose-dependent insulin secretion from pancreatic beta cells, glucagon suppression, delayed gastric emptying and reduced food intake through vagal and central pathways.
Regulatory history: Not approved in the United States. Marketed in China for type 2 diabetes, and approved by China's National Medical Products Administration in July 2023 for weight management.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Beinaglutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Beinaglutide in other countries
Frequently asked questions
Is Beinaglutide legal in the United States?
No. Beinaglutide is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: No FDA approval. Approved and marketed in China, including a weight management indication granted in July 2023.
Can I buy Beinaglutide in the United States?
No approved product exists to buy. In the United States Beinaglutide is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No FDA approval. Approved and marketed in China, including a weight management indication granted in July 2023.
Is Beinaglutide FDA approved?
No. FDA status: Not approved in the United States. Marketed in China for type 2 diabetes, and approved by China's National Medical Products Administration in July 2023 for weight management.. Current US classification: "Not approved; research use only". On the evidence, 3 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Beinaglutide live on its compound profile.
Beinaglutide profileThis page is general information about the regulatory status of Beinaglutide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.